Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N.

J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.

PMID:
29523663
2.

Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma.

El Behery R, Laurini JA, Weisenburger DD, Smith LM, Dave BJ, Yuan J, Fu K, Chan WC, Nathwani BN, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Greiner TC, Aoun P.

Hum Pathol. 2018 Feb;72:180-190. doi: 10.1016/j.humpath.2017.11.002. Epub 2017 Nov 21.

PMID:
29170017
3.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.

Aldoss I, Pham A, Li SM, Gendzekhadze K, Afkhami M, Telatar M, Hong H, Padeganeh A, Bedell V, Cao T, Khaled SK, Malki MMA, Salhotra A, Ali H, Aribi A, Palmer J, Aoun P, Spielberger R, Stein AS, Snyder D, O'Donnell MR, Murata-Collins J, Senitzer D, Weisenburger D, Forman SJ, Pullarkat V, Marcucci G, Pillai R, Nakamura R.

Haematologica. 2017 Dec;102(12):2030-2038. doi: 10.3324/haematol.2017.172544. Epub 2017 Sep 29.

4.

NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.

Brown PA, Shah B, Fathi A, Wieduwilt M, Advani A, Aoun P, Barta SK, Boyer MW, Bryan T, Burke PW, Cassaday R, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Frankfurt O, Greer JP, Kantarjian HM, Klisovic RB, Kupfer G, Litzow M, Liu A, Mattison R, Park J, Rubnitz J, Saad A, Uy GL, Wang ES, Gregory KM, Ogba N.

J Natl Compr Canc Netw. 2017 Sep;15(9):1091-1102. doi: 10.6004/jnccn.2017.0147.

PMID:
28874594
5.

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy.

Yuan J, Greiner TC, Fu K, Smith LM, Aoun P, Chan WC, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Weisenburger DD.

Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):488-497.e2. doi: 10.1016/j.clml.2017.06.006. Epub 2017 Jun 16.

PMID:
28842137
6.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H.

J Natl Compr Canc Netw. 2017 May;15(5):608-638.

PMID:
28476741
7.

Regulation of Pulsatile and Entropic ACTH Secretion Under Fixed Exogenous Secretagogue Clamps.

Roelfsema F, Aoun P, Takahashi PY, Erickson D, Yang R, Veldhuis JD.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2611-2619. doi: 10.1210/jc.2017-00115.

8.

Pulsatile Cortisol Feedback on ACTH Secretion Is Mediated by the Glucocorticoid Receptor and Modulated by Gender.

Roelfsema F, Aoun P, Veldhuis JD.

J Clin Endocrinol Metab. 2016 Nov;101(11):4094-4102. Epub 2016 Aug 22.

9.

Acute Lymphoblastic Leukemia, Version 2.2015.

Alvarnas JC, Brown PA, Aoun P, Ballen KK, Barta SK, Borate U, Boyer MW, Burke PW, Cassaday R, Castro JE, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Douer D, Frankfurt O, Greer JP, Johnson RA, Kantarjian HM, Klisovic RB, Kupfer G, Litzow M, Liu A, Rao AV, Shah B, Uy GL, Wang ES, Zelenetz AD, Gregory K, Smith C.

J Natl Compr Canc Netw. 2015 Oct;13(10):1240-79.

PMID:
26483064
10.

Hodgkin lymphoma, version 2.2015.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 May;13(5):554-86.

11.

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.

Caponetti GC, Dave BJ, Perry AM, Smith LM, Jain S, Meyer PN, Bast M, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Aoun P, Fu K, Greiner TC, Chan WC, Sanger WG, Weisenburger DD.

Leuk Lymphoma. 2015;56(11):3082-9. doi: 10.3109/10428194.2015.1034699. Epub 2015 May 12.

PMID:
25827211
12.

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care.

Bowen JM, Perry AM, Laurini JA, Smith LM, Klinetobe K, Bast M, Vose JM, Aoun P, Fu K, Greiner TC, Chan WC, Armitage JO, Weisenburger DD.

Br J Haematol. 2014 Jul;166(2):202-8. doi: 10.1111/bjh.12880. Epub 2014 Apr 4.

PMID:
24697285
13.

Estradiol, but not testosterone, heightens cortisol-mediated negative feedback on pulsatile ACTH secretion and ACTH approximate entropy in unstressed older men and women.

Sharma AN, Aoun P, Wigham JR, Weist SM, Veldhuis JD.

Am J Physiol Regul Integr Comp Physiol. 2014 May;306(9):R627-35. doi: 10.1152/ajpregu.00551.2013. Epub 2014 Feb 26.

14.

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Perry AM, Alvarado-Bernal Y, Laurini JA, Smith LM, Slack GW, Tan KL, Sehn LH, Fu K, Aoun P, Greiner TC, Chan WC, Bierman PJ, Bociek RG, Armitage JO, Vose JM, Gascoyne RD, Weisenburger DD.

Br J Haematol. 2014 May;165(3):382-91. doi: 10.1111/bjh.12763. Epub 2014 Feb 8.

PMID:
24506200
15.

Gender determines ACTH recovery from hypercortisolemia in healthy older humans.

Sharma A, Aoun P, Wigham J, Weist S, Veldhuis JD.

Metabolism. 2013 Dec;62(12):1819-29. doi: 10.1016/j.metabol.2013.08.014. Epub 2013 Sep 25.

16.

MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.

Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, Bhagavathi S, Greiner TC, Weisenburger DD, Aoun P, Perkins SL, McKeithan TW, Inghirami G, Chan WC.

Blood. 2013 Sep 19;122(12):2083-92. doi: 10.1182/blood-2012-08-447375. Epub 2013 Jun 25.

17.

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma.

Mitrovic Z, Iqbal J, Fu K, Smith LM, Bast M, Greiner TC, Aoun P, Armitage JO, Vose JM, Weisenburger DD, Chan WC.

Br J Haematol. 2013 Jul;162(1):87-92. doi: 10.1111/bjh.12356. Epub 2013 Apr 25.

PMID:
23617469
18.

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.

Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM, Aoun P, Chan WC, Fu K, Greiner TC, Bierman P, Gregory Bociek R, Vose JM, Armitage JO, Weisenburger DD.

Br J Haematol. 2013 Jul;162(1):40-9. doi: 10.1111/bjh.12343. Epub 2013 Apr 18.

PMID:
23600716
19.

Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis.

Perry AM, Aoun P, Coulter DW, Sanger WG, Grant WJ, Coccia PF.

Blood. 2013 Feb 21;121(8):1377-83. doi: 10.1182/blood-2012-06-438549. Epub 2012 Dec 18.

20.

Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.

Laurini JA, Aoun P, Iqbal J, Chan W, Greiner TC.

Am J Clin Pathol. 2012 Dec;138(6):877-83. doi: 10.1309/AJCP5TWORA0TMXGL.

PMID:
23161722
21.

Acute lymphoblastic leukemia.

Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M, Gregory KM; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Jul 1;10(7):858-914.

PMID:
22773801
22.

Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.

Gilling CE, Mittal AK, Chaturvedi NK, Iqbal J, Aoun P, Bierman PJ, Bociek RG, Weisenburger DD, Joshi SS.

Br J Haematol. 2012 Jul;158(2):216-231. doi: 10.1111/j.1365-2141.2012.09148.x. Epub 2012 May 10.

PMID:
22571278
23.

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 May;10(5):589-97.

PMID:
22570290
24.

Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report.

Prodduturi P, Perry AM, Aoun P, Weisenburger DD, Akhtari M.

J Oncol Pharm Pract. 2012 Dec;18(4):440-4. doi: 10.1177/1078155212438112. Epub 2012 Mar 7.

PMID:
22399151
25.

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.

Gu K, Weisenburger DD, Fu K, Chan WC, Greiner TC, Aoun P, Smith LM, Bast M, Liu Z, Bociek RG, Bierman PJ, Armitage JO, Vose JM.

Hematol Oncol. 2012 Sep;30(3):143-9. doi: 10.1002/hon.1017. Epub 2011 Oct 18.

26.

Tripartite control of dynamic ACTH-cortisol dose responsiveness by age, body mass index, and gender in 111 healthy adults.

Veldhuis JD, Iranmanesh A, Roelfsema F, Aoun P, Takahashi P, Miles JM, Keenan DM.

J Clin Endocrinol Metab. 2011 Sep;96(9):2874-81. doi: 10.1210/jc.2011-0084. Epub 2011 Jul 13.

27.

Overnight ACTH-cortisol dose responsiveness: comparison with 24-h data, metyrapone administration and insulin-tolerance test in healthy adults.

Iranmanesh A, Keenan DM, Aoun P, Veldhuis JD.

Clin Endocrinol (Oxf). 2011 Nov;75(5):596-601. doi: 10.1111/j.1365-2265.2011.04125.x.

28.

Pathology economic model tool: a novel approach to workflow and budget cost analysis in an anatomic pathology laboratory.

Muirhead D, Aoun P, Powell M, Juncker F, Mollerup J.

Arch Pathol Lab Med. 2010 Aug;134(8):1164-9. doi: 10.1043/2000-0401-OA.1.

PMID:
20670137
29.

t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.

Gu K, Fu K, Jain S, Liu Z, Iqbal J, Li M, Sanger WG, Weisenburger DD, Greiner TC, Aoun P, Dave BJ, Chan WC.

Mod Pathol. 2009 Sep;22(9):1251-7. doi: 10.1038/modpathol.2009.81. Epub 2009 May 22.

30.

Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report.

Naushad H, Choi WW, Page CJ, Sanger WG, Weisenburger DD, Aoun P.

Cytometry B Clin Cytom. 2009 May;76(3):218-24. doi: 10.1002/cyto.b.20463.

31.

Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.

Young KH, Xie Q, Zhou G, Eickhoff JC, Sanger WG, Aoun P, Chan WC.

Am J Clin Pathol. 2008 Jan;129(1):157-66.

PMID:
18089500
32.

Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.

Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS.

Int J Mol Med. 2007 Oct;20(4):461-9.

PMID:
17786276
33.

Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.

Aoun P, Zhou G, Chan WC, Page C, Neth K, Pickering D, Sanger W, Quinn-Laquer B, Watson P, Lynch JF, Lynch HT, Weisenburger DD.

Am J Clin Pathol. 2007 Jan;127(1):31-8.

PMID:
17145621
34.

Granulocytic sarcoma of the small intestine.

Kohl SK, Aoun P.

Arch Pathol Lab Med. 2006 Oct;130(10):1570-4. Review.

PMID:
17090205
35.

Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.

Natkunam Y, Hsi ED, Aoun P, Zhao S, Elson P, Pohlman B, Naushad H, Bast M, Levy R, Lossos IS.

Blood. 2007 Jan 1;109(1):298-305. Epub 2006 Sep 5.

36.

Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common.

Pirruccello SJ, Young KH, Aoun P.

Am J Clin Pathol. 2006 Jun;125(6):884-94.

PMID:
16690488
37.

Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.

Mikuls TR, Endo JO, Puumala SE, Aoun PA, Black NA, O'Dell JR, Stoner JA, Boilesen EC, Bast MA, Bergman DA, Ristow KM, Ooi M, Armitage JO, Habermann TM.

J Clin Oncol. 2006 Apr 1;24(10):1597-602. Epub 2006 Mar 6.

PMID:
16520462
38.

Long-term enhancement of maze learning in mice via a generalized Mozart effect.

Aoun P, Jones T, Shaw GL, Bodner M.

Neurol Res. 2005 Dec;27(8):791-6.

PMID:
16354537
39.

9q34 rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia.

Dave BJ, Wiggins M, Higgins CM, Pickering DL, Perry D, Aoun P, Abromowich M, DeVetten M, Sanger WG.

Cancer Genet Cytogenet. 2005 Oct 1;162(1):30-7.

PMID:
16157197
40.

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.

Hans CP, Weisenburger DD, Greiner TC, Chan WC, Aoun P, Cochran GT, Pan Z, Smith LM, Lynch JC, Bociek RG, Bierman PJ, Vose JM, Armitage JO.

Mod Pathol. 2005 Oct;18(10):1377-84.

41.

Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity.

Kumar DM, Perez E, Cai ZY, Aoun P, Brun-Zinkernagel AM, Covey DF, Simpkins JW, Agarwal N.

Free Radic Biol Med. 2005 May 1;38(9):1152-63. Erratum in: Free Radic Biol Med. 2005 Dec 15;39(12):1676.

PMID:
15808412
42.

Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.

Aoun P, Wiggins M, Pickering D, Foran J, Rasheed H, Pavletic SZ, Sanger W.

Cancer Genet Cytogenet. 2004 Oct 15;154(2):138-43.

PMID:
15474149
43.

Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.

Aoun P, Blair HE, Smith LM, Dave BJ, Lynch J, Weisenburger DD, Pavletic SZ, Sanger WG.

Leuk Lymphoma. 2004 Aug;45(8):1595-603.

PMID:
15370211
44.

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.

Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO.

Leuk Lymphoma. 2004 Aug;45(8):1551-7.

PMID:
15370206
45.

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.

Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO; Nebraska Lymphoma Study Group.

Leuk Lymphoma. 2003 Nov;44(11):1903-10.

PMID:
14738141
46.

Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.

Aoun P, Watson DG, Simpkins JW.

Eur J Pharmacol. 2003 Jul 4;472(1-2):65-71.

PMID:
12860474
47.

Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.

Aoun P, Simpkins JW, Agarwal N.

Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2999-3004.

PMID:
12824244
48.

Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations.

Papenfuss JS, Aoun P, Bierman PJ, Armitage JO.

Clin Lymphoma. 2002 Dec;3(3):175-80.

PMID:
12521396
49.

The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade.

Lawnicki LC, Weisenburger DD, Aoun P, Chan WC, Wickert RS, Greiner TC.

Am J Clin Pathol. 2002 Nov;118(5):765-72.

PMID:
12428798
50.

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.

Hans CP, Weisenburger DD, Vose JM, Hock LM, Lynch JC, Aoun P, Greiner TC, Chan WC, Bociek RG, Bierman PJ, Armitage JO.

Blood. 2003 Mar 15;101(6):2363-7. Epub 2002 Nov 7.

Supplemental Content

Support Center